Open Access
Issue
J Oral Med Oral Surg
Volume 24, Number 2, June 2018
Page(s) 57 - 59
Section Cas clinique / Short case report
DOI https://doi.org/10.1051/mbcb/2017037
Published online 29 June 2018
  1. Aldosa J, Curien R, Guillet J, Gangloff P, Gerard E. Hereditary hemorrhagic telangiectasia revealed by oro-facial telangiectasia. J Oral Surg Oral Med 2014;20:125–127. [EDP Sciences] [Google Scholar]
  2. Chami B, Cherkaoui A, Sahnoun I, El Wady W. Osler–Weber–Rendu: orofacial manifestations and therapeutic attitude in odontology. J Oral Surg Oral Med 2006;12:213–219. [EDP Sciences] [Google Scholar]
  3. Duffau P, Lazarro E, Viallard JF. Osler-Weber-Rendu disease. Rev Med Int 2014;35:21–27. [CrossRef] [Google Scholar]
  4. Shovlin CL. Hereditary hemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203–219. [CrossRef] [PubMed] [Google Scholar]
  5. French National Authority for Health. Osler-Weber-Rendu disease. National protocol for diagnosis and care. Paris: HAS, 2009. [Google Scholar]
  6. Corre P, Perret C, Isidor B, Khonsari RH. A brain abscess following dental extractions in a patient with hereditary hemorrhagic telangiectasia. Br J Oral Maxillofac Surg 2010;49:9–11. [CrossRef] [PubMed] [Google Scholar]
  7. Richer SL, Geisthoff UW, Livada N, Ward PD, Johnson L, Mainka A, et al. The Young’s procedure for severe epistaxis from hereditary hemorrhagic telangiectasia. Am J Rhinol Allergy 2012;26:401–404. [CrossRef] [PubMed] [Google Scholar]
  8. Lebrin F, Srun S, Raymond K, Martin S, Van Den Brink S, Freitas C, Bréant C, Mathivet T, Larrivée B, Thomas JL, Arthur HM, Westermann CJ, Disch F, Mager JJ, Snijder RJ, Eichmann A, Mummery CL. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med 2010;16:420–428. [CrossRef] [PubMed] [Google Scholar]
  9. Arizmendez NP, Rudmik L, Poetker DM. Intravenous bevacizumab for complications of hereditary hemorrhagic telangiectasia: a review of the literature. Int Forum Allergy Rhinol 2015;5:1042–1047. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.